Eisai Transfers Rights to Receive Royalties Outside of Japan for EZH2 Inhibitor Tazemetostat to Royalty Pharma
- Written by ACN Newswire - Press Releases
Tazemetostat is a first-in-class, oral EZH2 inhibitor discovered by Epizyme,...
.
More Articles ...
- Innovation and Investment Seen as Growth Drivers for Asia's Transition to Clean Energy - Asia Clean Energy Summit 2019
- 1,500 Energy Experts Gather in Bangkok in November to Secure Thailand's Energy Future
- Upgraded Version of Tokyo Stock Exchange's arrowhead Trading System
- WiseSpot Partners With Sigma Systems On Enterprise Product Catalog System For SmarTone
- MX Token Officially Launched on Huobi Global
- Robert Parker Wine Advocate's Matter of Taste returns to New York City for its Fourth and Most Exciting Edition on November 23
- Sheng Ye Capital Reaches Strategic Cooperation Agreement with China Construction Bank Shenzhen Branch
- Fujitsu RunMyProcess Seamlessly Connects People and Things with DigitalSuite Business Fabric Ecosystem
- RETRANSMISSION: TransCanna and Lyfted Farms Sign Definitive Purchase Agreement
- Injecting green elements into the production chain
Magazine
Compressed Air Pipe and Fittings: What Every Australian Industrial Facility Needs to Know
Compressed air is the fourth utility of modern industry, right alongside electricity, gas, and water. Yet despite its critical role in powering everything from pneumatic tools to automated productio...
Common Risks Hidden in Commercial Lease Agreements
Commercial leases are often longer and more complex than tenants expect, and the fine print can carry significant financial and operational consequences over the years that follow. Many business own...
Corporate Secretarial Services in Singapore: Annual Compliance, Key Filings, and Common Mistake
Annual compliance in Singapore should not be treated as a once-a-year administrative event. It is an ongoing governance system that depends on accurate records, timely filings, disciplined approvals...